Back |
home / stock / rytm / rytm message board
Subject | By | Source | When |
---|---|---|---|
For some reason it is tanking now -sale | Amatuer17 | investorshub | 01/26/2021 6:12:28 PM |
$RYTM is not cheap as it has market | midastouch017 | investorshub | 01/26/2021 4:34:29 PM |
You can actually wait for some time and | Amatuer17 | investorshub | 01/26/2021 4:19:37 PM |
I missed out this one! | midastouch017 | investorshub | 01/26/2021 1:29:54 PM |
Just amazing results - they are starting new | Amatuer17 | investorshub | 01/26/2021 1:25:59 PM |
Head the conf call - It was good | Amatuer17 | investorshub | 12/22/2020 10:53:03 PM |
Phase 3 results - BBS stat significant -AL | Amatuer17 | investorshub | 12/22/2020 1:02:23 PM |
znewcar1: RYTM 21% v1,6M c29.27 f44,2M H31.24 | znewcar1 | investorshangout | 11/27/2020 7:43:03 PM |
Finally - Approval Rhythm Pharmaceuticals Announces FDA Approval of | Amatuer17 | investorshub | 11/27/2020 12:44:56 PM |
Thats a big run with PDUFA being in | grich1 | investorshub | 08/30/2020 6:53:04 PM |
Good call! | midastouch017 | investorshub | 08/28/2020 1:45:53 PM |
What is happening? Looks good | Amatuer17 | investorshub | 08/27/2020 6:17:51 PM |
Not so sure the last few years. | midastouch017 | investorshub | 08/10/2020 6:43:30 AM |
$RYTM is not cheap as it has market | Amatuer17 | investorshub | 08/10/2020 2:59:43 AM |
Not so sure the last few years. But | pennyrich | investorshub | 08/09/2020 7:13:09 PM |
Sure. A free country, isn't it? | midastouch017 | investorshub | 08/09/2020 7:06:30 PM |
Can anyone play??? | pennyrich | investorshub | 08/09/2020 6:41:27 PM |
Thanks for the heads up Amatuer17, | midastouch017 | investorshub | 08/08/2020 12:35:15 PM |
Welcome to the board. Hope we all make | Amatuer17 | investorshub | 08/08/2020 12:29:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Rhythm Pharmaceuticals Inc. Company Name:
RYTM Stock Symbol:
NASDAQ Market:
Rhythm Pharmaceuticals Inc. Website:
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a commercial-stage biopharmaceutical company focused on tra...
-- First quarter 2024 net revenue from global sales of IMCIVREE® (setmelanotide) of $26.0 million -- -- On track to submit sNDA to the FDA to...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...